Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Clonidine in Sympathetic Hyperactivity after Moderate TBI
NCT04833218Phase 1Unknown
- Sponsor
- Minia University
- Start
- Jan 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of propranolol and clonidine in traumatic brain injury (TBI), sponsored by Minia University. Primary endpoint: Catecholamine level at 7 days. Status: unknown.
02
Drugs
propranololclonidine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04833218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833218.